HARVARD BIOSCIENCE, INC. (HBIO) Gross margin 2016–2025
HARVARD BIOSCIENCE, INC. (HBIO) gross margin by fiscal year — reported gross profit divided by reported revenue.
57.7%FY2025 · since FY2016: 46.3% → 57.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 57.7% | -0.5 pp |
| FY2024 | 58.2% | -0.7 pp |
| FY2023 | 58.9% | +5.2 pp |
| FY2022 | 53.7% | -3.2 pp |
| FY2021 | 56.9% | +0.0 pp |
| FY2020 | 56.8% | +1.5 pp |
| FY2019 | 55.4% | +3.1 pp |
| FY2018 | 52.3% | +1.7 pp |
| FY2017 | 50.6% | +4.3 pp |
| FY2016 | 46.3% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice